Cherwell appoints product specialist
January 11, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cherwell Laboratories
Pharma supplier firm Cherwell Laboratories has announced the appointment of Abdulmajeed Raji as microbiology product specialist. Prior to joining Cherwell, …
FDA vote on J&J diabetes drug
January 10, 2013Sales and Marketing EU, FDA, J&J, JJ, Janssen, canagliflozin
Key advisers to the FDA are meeting today to decide whether Janssen Pharmaceuticals’ type II diabetes drug canagliflozin is safe …
Hookipa Biotech hires two officers
January 10, 2013Manufacturing and Production, Research and Development, Sales and Marketing Farshad Guirakhoo, Hookipa, Thomas Monarth
Vaccines biotech firm Hookipa Biotech AG has appointed two new members to its management team. Thomas Monath (pictured) joins as …
Global agency network welcomes new members
January 10, 2013Medical Communications Indigenus, Lindh & Partners, PharMa International
A global network of independent healthcare agencies has welcomed two new members to the group. Tokyo-based PharMa International and Swedish …
£120m health research boost
January 10, 2013Sales and Marketing Hunt, NHS, NIHR, TXA
The Department of Health is putting £120 million of new funding into health research over the next five years in …
CQC ‘needs urgent overhaul’, say MPs
January 9, 2013Sales and Marketing CQQ, Dorrell, NHS, select committee
England’s health and social care regulator, the Care Quality Commission (CQC), must overhaul its governance structures ‘as a matter of …
Gilead licences MacroGenics technology
January 9, 2013Research and Development, Sales and Marketing DART, Gilead, MacroGenics
Private biotech company MacroGenics has licenced its bi-specific antibody platform technology to Gilead Sciences for products aimed at four unnamed …
MAPI Group hires James Karis as chief executive
January 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing James Karis, MAPI
Healthcare services group MAPI has named James Karis as its chief executive. MAPI looks to Karis to consolidate its success …
SHL to present & exhibit at 10th Annual BIO Asia International Conference
January 9, 2013Manufacturing and Production auto injector, autoinjector, shl events
SHL will be presenting and exhibiting at the upcoming 10th Annual BIO Asia International Conference from January 29-30th in Tokyo, …
Private equity firm pays $195m for contract manufacturer JHP
January 8, 2013Manufacturing and Production CMO, JHP, Warburg Pincus
Private equity group Warburg Pincus has acquired sterile injectable drug manufacturer JHP Pharmaceuticals from its current owner Morgan Stanley. The …
Questcor buys API specialist BioVectra for $51m
January 8, 2013Manufacturing and Production API, Achtar, BioVectra, Questcor
US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …
Boehringer hands back Lilly drug
January 8, 2013Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly
Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …
Valeant shuts plant in Brazil, second to follow
January 8, 2013Manufacturing and Production Brazil, Medicis, Valeant
Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the …
Eisai and Novartis part ways
January 8, 2013Sales and Marketing COPD, Eisai, Novartis, Onbrez, Spiriva
Novartis and Eisai have abandoned their co-promotion agreement for three of Novartis’ chronic obstructive pulmonary disease treatments. The move follows …
Novo Nordisk appoints Curtis Oltmans to US executive team
January 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Oltmans
Novo Nordisk has announced that Curtis Oltmans has been promoted to corporate vice president and general counsel, Legal and Quality …
Marketing excellence: how to win over your internal audience
January 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Manastersky, marketing
You’ve spent months building a marketing excellence training curriculum which has been prioritised by marketing leadership as a critically important …
David Cook appointed chief financial officer of Biotie
January 7, 2013Manufacturing and Production, Research and Development, Sales and Marketing Biotie, David Cook
David Cook has been appointed chief financial officer (CFO) of drug development firm Biotie Therapies and will become a member …
AbbVie splits from Abbott
January 7, 2013Sales and Marketing AbbVie, Abbott, HIV, Humira
AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …
Pressure on pharma M&A
January 7, 2013Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers
The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …
New price and data changes NICE view on Lucentis
January 4, 2013Sales and Marketing Bayer, Eylea, Lucentis, NICE, Novartis
A new lower price and new data analysis has persuaded NICE to recommend Lucentis for patients with diabetic macular oedema …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
